Skip to content

Rapid Micro Biosystems RPID Non-cash lease expense

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept rmb:LeasesNoncashExpense.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's non-cash lease expense.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's non-cash lease expense?
Rapid Micro Biosystems (RPID) reported non-cash lease expense of $305K in Q1 2026.
How has Rapid Micro Biosystems's non-cash lease expense changed year-over-year?
Rapid Micro Biosystems's non-cash lease expense decreased by 0.0% year-over-year, from $305K to $305K.
What is the long-term trend for Rapid Micro Biosystems's non-cash lease expense?
Over 2 years (2022 to 2024), Rapid Micro Biosystems's non-cash lease expense has grown at a 1.0% compound annual growth rate (CAGR), from $1.14M to $1.17M.